Warburg Pincus Private Equity XI, L.P.
Director10% Owner

Warburg Pincus Private Equity XI, L.P. insider trades: Sotera Health (SHC) stock sales

Director, Sotera Health Last trade May 13, 2026 10 Form 4 filings
$571.5M
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2019
3
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Warburg Pincus Private Equity XI, L.P. reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 13, 2026SHC↓ Sell$289.8M
Nov 10, 2025SHC↓ Sell$281.7M
Sep 5, 2025SHC↓ Sell$181.3M
Sep 6, 2024SHC↓ Sell$225.4M
Mar 4, 2024SHC↓ Sell$237.4M
Mar 22, 2021SHC↓ Sell$353.0M
May 20, 2019AVLR↓ Sell$306.4M
Feb 19, 2019AVLR↓ Sell$230.4M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other SHC insiders

Open-market trades in the last 12 months

About Warburg Pincus Private Equity XI, L.P.'s insider trades

Warburg Pincus Private Equity XI, L.P. is a director at Sotera Health (SHC). Since Feb 19, 2019, it has reported no open-market purchases and 8 sales worth $2.11B on SEC Form 4. In the last 12 months: 2 sales ($571.5M).

Its filings also include shares returned to the company (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SHC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.